ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

New CAR-T Cancer Studies Aim to Treat Those With No Other Options – Futurism

Continue reading

2017-12-11 Michael Zand NEWS

New CAR-T Cancer Studies Aim to Treat Those With No Other Options – Futurism


Futurism

New CAR-T Cancer Studies Aim to Treat Those With No Other Options
Futurism
Two studies have been published detailing the results of clinical trials involving CAR-T treatment, where a patient’s own T-cells are used to fight cancer.
CAR T Progress: Global Submissions for Kymriah, 42% Ongoing Response With Yescarta in ZUMA-1 PatientsAJMC.com Managed Markets Network
India: US FDA Approves Yescarta™ (Axicabtagene Ciloleucel): Becomes First CAR T Therapy Approved For The …Mondaq News Alerts
ASH: Long-term CAR-T data look good for Gilead—but good …FiercePharma
StreetInsider.com –Pharmacy Today, American Pharmacists Association, pharmacist.com
all 13 news articles »
Continue reading

2017-12-11 Michael Zand NEWS

CRISPR: Five Ways to Maximize Its Potential – R & D Magazine

R & D MagazineCRISPR: Five Ways to Maximize Its PotentialR & D MagazineIn 2011, only 86 articles in the scientific literature cited the gene-editing technology, CRISPR (clustered regularly interspaced short palindromic repeats). By the end of 2016, tha… Continue reading

2017-12-11 Michael Zand NEWS

A CRISPR system to turn genes on : Research Highlights – Nature – Nature.com

Nature.comA CRISPR system to turn genes on : Research Highlights – NatureNature.comNew technique modifies gene expression instead of actual DNA.Searching for the CRISPR Swiss-army knifeEurekAlert (press release)CRISPR has success in treating mice with … Continue reading

2017-12-11 Michael Zand NEWS

Synthetic Biology Market is Expected to Grow Due to Increasing Uses of Environmental Applications – Hexa Research – Digital Journal

Synthetic Biology Market is Expected to Grow Due to Increasing Uses of Environmental Applications – Hexa ResearchDigital JournalGrowth Drivers of "Synthetic Biology Market" are high incidence of diabetes, the problem of obesity, growing geria… Continue reading

2017-12-11 Michael Zand NEWS

Patients’ individual genomes may affect efficacy, safety of gene editing – Science Daily


Futurism

New CAR-T Cancer Studies Aim to Treat Those With No Other Options
Futurism
Two studies have been published detailing the results of clinical trials involving CAR-T treatment, where a patient’s own T-cells are used to fight cancer.
CAR T Progress: Global Submissions for Kymriah, 42% Ongoing Response With Yescarta in ZUMA-1 PatientsAJMC.com Managed Markets Network
India: US FDA Approves Yescarta™ (Axicabtagene Ciloleucel): Becomes First CAR T Therapy Approved For The …Mondaq News Alerts
ASH: Long-term CAR-T data look good for Gilead—but good …FiercePharma
StreetInsider.com –Pharmacy Today, American Pharmacists Association, pharmacist.com
all 13 news articles »
Continue reading

2017-12-11 Michael Zand NEWS

Dr. McKay Discusses Immunotherapy Trials in RCC – OncLive

Dr. McKay Discusses Immunotherapy Trials in RCCOncLiveRana R. McKay, MD, medical oncologist, assistant professor, Moores Cancer Center at the University of California, San Diego, discusses immunotherapy trials in renal cell carcinoma (RCC). Data presen… Continue reading

2017-12-11 Michael Zand NEWS

New trials show cancer immunotherapy can be incredibly effective—and incredibly dangerous – Popular Science

Patients’ individual genomes may affect efficacy, safety of gene editing
Science Daily
The study analyzed 7,444 previously published whole-genome sequences. Based on a list of about 30 disease-related DNA targets that researchers are interested in altering through gene editing, the researchers made a second list of nearly 3,000 guide …

Continue reading

2017-12-11 Michael Zand NEWS
  • 1
  • …
  • 798
  • 799
  • 800
  • 801
  • 802
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Popular Science

New trials show cancer immunotherapy can be incredibly effective—and incredibly dangerous
Popular Science
In the past decade, immunotherapies have become an increasingly promising way of combatting cancer. Most of them work by hijacking the body’s immune system and employing it to fight disease. But one treatment has arguably shown the most promise …
Fighting the disease: Novel immunotherapy brings new hope for cancer patientsHindustan Times
New immunotherapy to help fight cancer developedGreater Kashmir
Global CAR T therapy trial shows high rates of durable remission for non-Hodgkin’s lymphomaScience Daily
KERA News
all 22 news articles »